Dashboard
Manage Tickers

ATAIATAI Life Sciences N.V.

Nasdaq atai.life


$ 1.35 $ 0.01 (0.75 %)    

Friday, 21-Jun-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.84 $ -1.29 (-0.27 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.96 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 1.34
$ 1.37
$ 0.00 x 0
$ 0.00 x 0
$ 1.30 - $ 1.41
$ 1.03 - $ 2.85
1,248,818
na
212.91M
$ 1.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 03-28-2024 12-31-2023 10-K
3 11-14-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-24-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-30-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cantor-fitzgerald-reiterates-overweight-on-atai-life-sciences
Cantor Fitzgerald Reiterates Overweight on...
06/21/2024 16:26:10

Cantor Fitzgerald analyst Charles Duncan reiterates ATAI Life Sciences (NASDAQ:ATAI) with a Overweight.

atai-life-sciences-announced-an-update-on-beckley-psytechs-phase-12a-trial-of-ele-101-for-major-depressive-disorder-with-initial-results-from-phase-1-and-the-dosing-of-the-first-patients-in-the-phase-2a-part-of-the-study
Atai Life Sciences Announced An Update On ...
06/20/2024 11:05:54

ELE-101 is a patent-protected, synthetic formulation of psilocin, designed to offer the therapeutic benefits of psilocybin in...

psychedelic-stocks-trip-up-after-fda-advisors-reject-mdma-for-ptsd-treatment
Psychedelic Stocks Trip Up After FDA Advis...
06/05/2024 19:26:42

FDA panel rejects MDMA therapy for PTSD, citing lack of evidence for benefits outweighing risks. Psychedelic stocks take a hit,...

whats-going-on-with-mindmed-and-psychedelic-stocks
What's Going On With MindMed And Psychedel...
06/05/2024 14:58:55

Mind Medicine (MindMed) shares are trading lower Wednesday after a Food and Drug Administration (FDA) panel rejected the approv...

hc-wainwright--co-reiterates-buy-on-atai-life-sciences-maintains-15-price-target
HC Wainwright & Co. Reiterates Buy on ATAI...
05/17/2024 17:16:08

HC Wainwright & Co. analyst Patrick Trucchio reiterates ATAI Life Sciences (NASDAQ:ATAI) with a Buy and maintains $15 pr...

atai-life-sciences-q1-eps-017-beats-018-estimate-cash-1887m
ATAI Life Sciences Q1 EPS $(0.17) Beats $(...
05/15/2024 11:57:21

ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(...

pot-company-gets-license-to-open-psilocybin-service-center-the-sacred-mushroom-in-oregon
Pot Company Gets License To Open Psilocybi...
05/09/2024 13:29:42

atai-life-sciences-disclosed-dosing-of-first-patient-in-part-2-of-beckley-psytechs-phase-2a-study-exploring-bpl-003-adjunctive-to-ssris-in-patients-with-treatment-resistant-depression
Atai Life Sciences Disclosed Dosing Of Fir...
04/24/2024 11:08:03

psyched-dea-revisits-ban-on-two-psychedelics-farewell-russell-newcombe-podcast-episode-on-kanna--more
Psyched: DEA Revisits Ban On Two Psychedel...
04/17/2024 12:42:33

atai-life-sciences-announces-the-publication-of-beckley-psytechs-phase-1-study-of-bpl-003-in-the-journal-of-psychopharmacology
ATAI Life Sciences Announces the Publicati...
04/17/2024 11:03:16

atai Life Sciences (NASDAQ:ATAI) ("atai" or "Company"), a clinical-stage biopharmaceutical company aiming to tr...

cantor-fitzgerald-reiterates-overweight-on-atai-life-sciences
Cantor Fitzgerald Reiterates Overweight on...
04/04/2024 13:54:39

Cantor Fitzgerald analyst Charles Duncan reiterates ATAI Life Sciences (NASDAQ:ATAI) with a Overweight.

why-ulta-beauty-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Ulta Beauty Shares Are Trading Lower B...
04/03/2024 17:56:10

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the ...

signet-jewelers-dave--busters-entertainment-blue-owl-capital-and-other-big-stocks-moving-higher-on-wednesday
Signet Jewelers, Dave & Buster's Entertain...
04/03/2024 14:31:14

U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday.

maxim-group-upgrades-atai-life-sciences-to-buy-announces-6-price-target
Maxim Group Upgrades ATAI Life Sciences to...
04/03/2024 14:02:10

Maxim Group analyst Jason McCarthy upgrades ATAI Life Sciences (NASDAQ:ATAI) from Hold to Buy and announces $6 price target.

hc-wainwright--co-maintains-buy-on-atai-life-sciences-lowers-price-target-to-15
HC Wainwright & Co. Maintains Buy on ATAI ...
04/03/2024 10:55:45

HC Wainwright & Co. analyst Patrick Trucchio maintains ATAI Life Sciences (NASDAQ:ATAI) with a Buy and lowers the price ...

psyched-5-meo-dmt-for-depression-utah-hospitals-providing-therapy-elon-musk-and-metas-influence
Psyched: 5-MeO-DMT For Depression, Utah Ho...
03/29/2024 16:43:17

atai-life-sciences-q4-and-full-year-2023-results-steep-cash-drain-yet-2026-target-remains-update-on-psychedelic-pipeline
Atai Life Sciences Q4 And Full-Year 2023 R...
03/29/2024 13:20:35

intranasal-5-meo-dmt-clinical-trial-offers-hope-for-treatment-resistant-depression
Intranasal 5-MeO-DMT Clinical Trial Offers...
03/28/2024 20:09:24

recap-atai-life-sciences-q4-earnings
Recap: ATAI Life Sciences Q4 Earnings
03/28/2024 11:55:06

atai-life-sciences-q4-eps-012-beats-016-estimate-sales-1800k-miss-19000k-estimate
ATAI Life Sciences Q4 EPS $(0.12) Beats $(...
03/28/2024 11:14:00

ATAI Life Sciences (NASDAQ:ATAI) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)